Indivior (INDV) Competitors GBX 914.50 +1.00 (+0.11%) (As of 12/20/2024 12:01 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades INDV vs. SOPH, HCM, ITH, GRI, SLS, ERGO, BMY, SLN, AMYT, and GPHShould you be buying Indivior stock or one of its competitors? The main competitors of Indivior include Sophos Group plc (SOPH.L) (SOPH), HUTCHMED (HCM), Ithaca Energy (ITH), Grainger (GRI), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Bloomsbury Publishing (BMY), Silence Therapeutics (SLN), Amryt Pharma (AMYT), and Global Ports (GPH). These companies are all part of the "pharmaceutical products" industry. Indivior vs. Sophos Group plc (SOPH.L) HUTCHMED Ithaca Energy Grainger Standard Life UK Smaller Companies Trust Ergomed Bloomsbury Publishing Silence Therapeutics Amryt Pharma Global Ports Indivior (LON:INDV) and Sophos Group plc (SOPH.L) (LON:SOPH) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, community ranking, profitability and risk. Which has higher earnings & valuation, INDV or SOPH? Sophos Group plc (SOPH.L) has lower revenue, but higher earnings than Indivior. Indivior is trading at a lower price-to-earnings ratio than Sophos Group plc (SOPH.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIndivior£1.15B1.02-£141M-£0.80-1,143.13Sophos Group plc (SOPH.L)£726.90M0.00N/A£1.70N/A Do insiders and institutionals have more ownership in INDV or SOPH? 86.0% of Indivior shares are held by institutional investors. 3.4% of Indivior shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is INDV or SOPH more profitable? Sophos Group plc (SOPH.L) has a net margin of 0.00% compared to Indivior's net margin of -12.29%. Indivior's return on equity of 12.20% beat Sophos Group plc (SOPH.L)'s return on equity.Company Net Margins Return on Equity Return on Assets Indivior-12.29% 12.20% 2.37% Sophos Group plc (SOPH.L) N/A N/A N/A Does the MarketBeat Community prefer INDV or SOPH? Indivior received 142 more outperform votes than Sophos Group plc (SOPH.L) when rated by MarketBeat users. Likewise, 80.43% of users gave Indivior an outperform vote while only 80.19% of users gave Sophos Group plc (SOPH.L) an outperform vote. CompanyUnderperformOutperformIndiviorOutperform Votes55980.43% Underperform Votes13619.57%Sophos Group plc (SOPH.L)Outperform Votes41780.19% Underperform Votes10319.81% Does the media prefer INDV or SOPH? In the previous week, Indivior had 7 more articles in the media than Sophos Group plc (SOPH.L). MarketBeat recorded 7 mentions for Indivior and 0 mentions for Sophos Group plc (SOPH.L). Indivior's average media sentiment score of 0.08 beat Sophos Group plc (SOPH.L)'s score of 0.00 indicating that Indivior is being referred to more favorably in the media. Company Overall Sentiment Indivior Neutral Sophos Group plc (SOPH.L) Neutral Do analysts prefer INDV or SOPH? Indivior currently has a consensus price target of GBX 1,650, suggesting a potential upside of 80.43%. Given Indivior's stronger consensus rating and higher possible upside, equities analysts clearly believe Indivior is more favorable than Sophos Group plc (SOPH.L).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Indivior 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Sophos Group plc (SOPH.L) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is INDV or SOPH a better dividend stock? Indivior pays an annual dividend of GBX 15 per share and has a dividend yield of 1.6%. Sophos Group plc (SOPH.L) pays an annual dividend of GBX 0.04 per share. Indivior pays out -1,875.0% of its earnings in the form of a dividend. Sophos Group plc (SOPH.L) pays out 2.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Indivior is clearly the better dividend stock, given its higher yield and lower payout ratio. SummaryIndivior beats Sophos Group plc (SOPH.L) on 14 of the 17 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Indivior News Delivered to You Automatically Sign up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INDV vs. The Competition Export to ExcelMetricIndiviorDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£1.18B£1.15B£5.13B£1.83BDividend Yield4.48%3.04%5.08%10.56%P/E Ratio-1,143.13131.2389.581,756.25Price / Sales1.021,962.971,116.12374,123.97Price / Cash2.6810.1142.8227.80Price / Book-10.163.064.772.88Net Income-£141M£152.21M£120.15M£155.16M7 Day Performance0.72%-0.48%-1.92%-1.90%1 Month Performance9.26%-1.32%11.47%17.32%1 Year Performance-21.90%98.66%30.52%28.55% Indivior Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INDVIndivior2.503 of 5 starsGBX 914.50+0.1%GBX 1,650+80.4%-22.5%£1.18B£1.15B-1,143.131,000Analyst ForecastSOPHSophos Group plc (SOPH.L)N/AGBX 580.40+1.0%N/AN/A£2.99B£726.90M341.41520HCMHUTCHMEDN/AGBX 239-3.2%N/A-12.9%£2.04B£610.81M-6,150.001,760ITHIthaca EnergyN/AGBX 107.80-0.4%N/A-29.3%£1.78B£1.91B901.67220GRIGrainger2.7255 of 5 starsGBX 226.50-1.7%GBX 317.50+40.2%-17.2%£1.67B£270.30M8,183.33372SLSStandard Life UK Smaller Companies TrustN/AGBX 732-1.3%N/A+0.0%£715.41M£222.48M3.3710ERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386BMYBloomsbury Publishing1.1247 of 5 starsGBX 682-2.3%GBX 825+21.0%+48.7%£555.42M£342.65M1,789.7434,300News CoverageGap DownSLNSilence TherapeuticsN/AGBX 535-0.9%N/A+0.0%£480.35M£11.35M-11.01100News CoveragePositive NewsHigh Trading VolumeAMYTAmryt PharmaN/AGBX 143-11.7%N/A+0.0%£457.11M£210.24M-4.33290Gap DownGPHGlobal PortsN/AGBX 300-4.5%N/A+18.8%£231.21M£193.58M30,000.0020 Related Companies and Tools Related Companies Sophos Group plc (SOPH.L) Alternatives HUTCHMED Alternatives Ithaca Energy Alternatives Grainger Alternatives Standard Life UK Smaller Companies Trust Alternatives Ergomed Alternatives Bloomsbury Publishing Alternatives Silence Therapeutics Alternatives Amryt Pharma Alternatives Global Ports Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:INDV) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indivior PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Indivior With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INDV Stock Alerts